Regeneron Pharmaceuticals Inc (REGN)
Receivables turnover
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 14,247,800 | 14,214,200 | 14,085,700 | 14,202,000 | 13,847,100 | 13,489,100 | 13,100,100 | 13,117,200 | 13,097,300 | 12,670,800 | 12,369,900 | 12,172,900 | 13,710,200 | 14,226,800 | 16,508,100 | 16,071,700 | 13,542,900 | 12,384,100 | 9,197,600 | 8,497,100 |
| Receivables | US$ in thousands | 5,687,100 | 5,610,000 | 5,561,000 | 6,211,900 | 6,107,100 | 5,717,100 | 5,222,200 | 5,667,300 | 5,584,500 | 5,121,300 | 5,118,600 | 5,328,700 | 5,548,300 | 5,161,400 | 4,839,000 | 6,036,500 | 5,452,000 | 6,998,600 | 4,173,000 | 4,114,700 |
| Receivables turnover | 2.51 | 2.53 | 2.53 | 2.29 | 2.27 | 2.36 | 2.51 | 2.31 | 2.35 | 2.47 | 2.42 | 2.28 | 2.47 | 2.76 | 3.41 | 2.66 | 2.48 | 1.77 | 2.20 | 2.07 |
September 30, 2025 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $14,247,800K ÷ $5,687,100K
= 2.51
Peer comparison
Sep 30, 2025
Company name
Symbol
Receivables turnover
Regeneron Pharmaceuticals Inc
REGN
2.51
Arrowhead Pharmaceuticals Inc
ARWR
121.55
Biomarin Pharmaceutical Inc
BMRN
3.92
See also:
Regeneron Pharmaceuticals Inc Receivables Turnover (Quarterly Data)